text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 128-13-2 | Product Number: U0030

Ursodeoxycholic Acid


Purity: >98.0%(T)
Synonyms:
  • 5β-Cholanic Acid-3α,7β-diol
  • 3α,7β-Dihydroxy-5β-cholanic Acid
Product Documents:
5G
$42.00
15   1  
25G
$138.00
27   11  

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.


Product Number U0030
Purity / Analysis Method >98.0%(T)
Molecular Formula / Molecular Weight C__2__4H__4__0O__4 = 392.58 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 128-13-2
Reaxys Registry Number 3219888
PubChem Substance ID 87577760
SDBS (AIST Spectral DB) 11242
Merck Index (14) 9889
MDL Number

MFCD00003680

Specifications
Appearance White to Almost white powder to crystaline
Purity(Neutralization titration) min. 98.0 %(after drying)
Melting point 200.0 to 205.0 °C
Specific rotation [a]20/D + 59.0 to + 62.0 deg(C=4, EtOH)
Solubility in EtOH almost transparency
Drying loss max. 1.0 %
Properties (reference)
Melting Point 203 °C
Specific Rotation 60.5° (C=4,EtOH)
Solubility in water Insoluble
Degree of solubility in water 20 mg/l   20 °C
Solubility (slightly sol. in) Chloroform
GHS
Related Laws:
RTECS# FZ2000000
Transport Information:
H.S.code* 2918.19-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
Application
Synthesis of Biaryls

Ursodeoxycholic acid (ursodiol or UDCA) is a main active compound of bile bear which has been widely used in traditional Chinese medicine for the purpose of promoting the flow of bile (choleretic effect). It is a secondary bile acid resulting from bacterial actions in the colon, and is normally present as a minor fraction of the total bile acids in humans. However, it alters bile acid composition, resulting in decreases in the concentration of the more hydrophobic and cytotoxic bile acids. Furthermore, some studies have suggested that ursodeoxycholic acid protects hepatocytes against bile acid-induced apoptosis. Recently, ursodeoxycholic acid is increasingly used for the treatment of cholestatic liver diseases. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.